𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Leukocytapheresis for the treatment of active pouchitis: a pilot study

✍ Scribed by Yasumi Araki; Keiichi Mitsuyama; Takaaki Nagae; Yuji Tou; Motonori Nakagawa; Yasue Iwatani; Masakazu Harada; Hiroyuki Ozasa; Michio Sata; Toshihiro Noake


Book ID
106180320
Publisher
Springer Japan
Year
2008
Tongue
English
Weight
430 KB
Volume
43
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Rifaximin for the treatment of active po
✍ Kim L. Isaacs; Robert S. Sandler; Maria Abreu; Michael F. Picco; Stephen B. Hana πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 132 KB πŸ‘ 2 views

## Background: The efficacy of the nonabsorbable antibiotic rifaximin in patients with active acute or chronic pouchitis is unknown. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of rifaximin in patients with active pouchitis. eighteen patients with

A pilot study of pioglitazone treatment
✍ Kittichai Promrat; Glen Lutchman; Gabriel I. Uwaifo; Renee J. Freedman; Alejandr πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 146 KB πŸ‘ 2 views

Nonalcoholic steatohepatitis (NASH) is a common chronic liver disease for which there is no known effective therapy. A proportion of patients with NASH progress to advanced fibrosis and cirrhosis. NASH is considered one of the clinical features of the metabolic syndrome in which insulin resistance p